Biomed Industries Announces Phase 3 Trials of NA-931 Targeting Durable Weight Loss & Lean-Mass Preservation at JPM Week

Biomed Industries, Inc. Announces Two NA-931 Phase 3 Trials, Targeting Durable Weight Loss & Lean-Mass Preservation ...

Crystalys Therapeutics Expands Phase 3 RUBY Study With First Patients Dosed at European Sites

Crystalys Therapeutics, a clinical-stage biopharmaceutical company addressing the significant unmet medical needs of people living with gout, today announced that the first patients have been dosed at ...
BioSpace

Novo’s Next-Gen Obesity Drug Beats Wegovy on Blood Sugar Control in Phase III

While CagriSema bested Novo Nordisk's Wegovy on blood sugar control in a late-stage trial, the next-gen weight loss drug still has not met the pharma's 25% weight loss goal.
Social Samosa

BFSI marketing 2026: The next phase of familiarity, trust, and AI

BFSI brands in 2026 are grappling with a digital-first and sceptical audience. In this story, BFSI leaders break down the ...
The Manila Times

Denali Therapeutics Presents Enzyme TransportVehicle™ Progress Across Three Clinical Programs for Treatment of Lysosomal Storage Disorders at 2026 WORLDSymposium™

Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness ...
The Manila Times

Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical ...
MedPage Today

Next-Generation Factor XIa Cuts Recurrent Stroke Risk by 26%

Among adults with acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack (TIA) with planned ...

DRDO tests SFDR propulsion for next-generation Astra Mk-3 missile

The Defence Research and Development Organisation (DRDO) on Tuesday successfully conducted a flight test of its Solid Fuel Ducted Ramjet (SFDR) techn ...
The Financial Express

India’s ‘broken’ cold chain is a Rs 2.3 trillion bottleneck—And these 2 niche giants just found the key

As India’s cold chain market targets double-digit growth through 2028, the $5 billion quick-commerce boom is forcing a ...
ZAWYA

Africa’s storage moment: Why end-to-end solutions are shaping the next phase of renewable growth

Africa’s renewable energy expansion is accelerating, led by solar deployment across East, West, and Southern Africa. Yet as ...

Ensysce Biosciences Provides Enrollment Update on Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid for Severe Acute Pain

Engineered to Deliver Potent Pain Relief with Built-In Abuse Protection ~ SAN DIEGO, CA / ACCESS Newswire / January 28, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a ...